Abstract:The outcome of bacterial infection management relies on prompt diagnosis and effective treatment, but conventional antimicrobial susceptibility testing can be slow and labor-intensive. Therefore, this study aims to predict phenotypic antimicrobial susceptibility of selected beta-lactam antimicrobials in the bacteria of the family Enterobacteriaceae from different beta-lactamase resistance genotypes. Using human datasets extracted from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program conducted by Pfizer and retail meat datasets from the National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), we used a robust or weighted least square multivariable linear regression modeling framework to explore the relationship between antimicrobial susceptibility data of beta-lactam antimicrobials and different types of beta-lactamase resistance genes. In humans, in the presence of the blaCTX-M-1, blaCTX-M-2, blaCTX-M-8/25, and blaCTX-M-9 groups, MICs of cephalosporins significantly increased by values between 0.34–3.07 μg/mL, however, the MICs of carbapenem significantly decreased by values between 0.81–0.87 μg/mL. In the presence of carbapenemase genes (blaKPC, blaNDM, blaIMP, and blaVIM), the MICs of cephalosporin antimicrobials significantly increased by values between 1.06–5.77 μg/mL, while the MICs of carbapenem antimicrobials significantly increased by values between 5.39–67.38 μg/mL. In retail meat, MIC of ceftriaxone increased significantly in the presence of blaCMY-2, blaCTX-M-1, blaCTX-M-55, blaCTX-M-65, and blaSHV-2 by 55.16 μg/mL, 222.70 μg/mL, 250.81 μg/mL, 204.89 μg/mL, and 31.51 μg/mL respectively. MIC of cefoxitin increased significantly in the presence of blaCTX-M-65 and blaTEM-1 by 1.57 μg/mL and 1.04 μg/mL respectively. In the presence of blaCMY-2, MIC of cefoxitin increased by an average of 8.66 μg/mL over 17 years. Compared to E. coli isolates, MIC of cefoxitin in Salmonella enterica isolates decreased significantly by 0.67 μg/mL. On the other hand, MIC of ceftiofur increased in the presence of blaCTX-M-1, blaCTX-M-65, blaSHV-2, and blaTEM-1 by 8.82 μg/mL, 9.11 μg/mL, 8.18 μg/mL, and 1.04 μg/mL respectively. In the presence of blaCMY-2, MIC of ceftiofur increased by an average of 10.20 μg/mL over 14 years. The ability to predict antimicrobial susceptibility of beta-lactam antimicrobials directly from beta-lactamase resistance genes may help reduce the reliance on routine phenotypic testing with higher turnaround times in diagnostic, therapeutic, and surveillance of antimicrobial-resistant bacteria of the family Enterobacteriaceae.

Prediction of antibiotic resistant strains of bacteria from their beta-lactamases protein

Predictive Modeling of Phenotypic Antimicrobial Susceptibility of Selected Beta-Lactam Antimicrobials from Beta-Lactamase Resistance Genes

Prediction of antibiotic resistance evolution by growth measurement of all proximal mutants of beta-lactamase

Prediction of Antibiotic Susceptibility in E. coli Isolates Using Machine Learning

Prediction of antimicrobial resistance based on whole-genome sequencing and machine learning

Prediction of antibiotic resistance in Escherichia coli from large-scale pan-genome data

Machine Learning Techniques for Antimicrobial Resistance Prediction of Pseudomonas Aeruginosa from Whole Genome Sequence Data

Machine Learning and Deep Learning Models for Predicting Noncovalent Inhibitors of AmpC β-Lactamase

Prediction of Antibiotic Resistance in Patients With a Urinary Tract Infection: Algorithm Development and Validation

Sequence-based modelling of bacterial genomes enables accurate antibiotic resistance prediction

Prediction of Linear Cationic Antimicrobial Peptides Active against Gram Negative and Positive Bacteria Based on Machine Learning Models

Prediction of antimicrobial resistance of Klebsiella pneumoniae from genomic data through machine learning

Identification of key drivers of antimicrobial resistance in Enterococcus using machine learning

A comparison of various feature extraction and machine learning methods for antimicrobial resistance prediction in streptococcus pneumoniae

ABDpred: Prediction of active antimicrobial compounds using supervised machine learning techniques

Suboptimal bioinformatic predictions of antimicrobial resistance from whole-genome sequences in multidrug-resistant Corynebacterium isolates

Machine learning techniques to identify antibiotic resistance in patients diagnosed with various skin and soft tissue infections

Prediction of Antibiotic Resistance Proteins from Sequence-Derived Properties Irrespective of Sequence Similarity

Predicting Antimicrobial Resistance in the Intensive Care Unit

AntiBP3: A Method for Predicting Antibacterial Peptides against Gram-Positive/Negative/Variable Bacteria

Prediction of antibiotic resistance at the patient level using deep learning